Style | Citing Format |
---|---|
MLA | Ebadi M, et al.. "Immunopathology and Immunotherapy of Hodgkin Lymphoma." Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, vol. , no. , 2015, pp. 117-134. |
APA | Ebadi M, Zeng Y, Gkotzamanidou M, Rezaei N (2015). Immunopathology and Immunotherapy of Hodgkin Lymphoma. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, (), 117-134. |
Chicago | Ebadi M, Zeng Y, Gkotzamanidou M, Rezaei N. "Immunopathology and Immunotherapy of Hodgkin Lymphoma." Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors , no. (2015): 117-134. |
Harvard | Ebadi M et al. (2015) 'Immunopathology and Immunotherapy of Hodgkin Lymphoma', Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors, (), pp. 117-134. |
Vancouver | Ebadi M, Zeng Y, Gkotzamanidou M, Rezaei N. Immunopathology and Immunotherapy of Hodgkin Lymphoma. Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors. 2015;():117-134. |
BibTex | @article{ author = {Ebadi M and Zeng Y and Gkotzamanidou M and Rezaei N}, title = {Immunopathology and Immunotherapy of Hodgkin Lymphoma}, journal = {Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors}, volume = {}, number = {}, pages = {117-134}, year = {2015} } |
RIS | TY - JOUR AU - Ebadi M AU - Zeng Y AU - Gkotzamanidou M AU - Rezaei N TI - Immunopathology and Immunotherapy of Hodgkin Lymphoma JO - Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors VL - IS - SP - 117 EP - 134 PY - 2015 ER - |